• Consensus Rating: Buy
  • Consensus Price Target: $76.91
  • Forecasted Upside: 14.13 %
  • Number of Analysts: 10
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 10 Buy Ratings
  • 0 Strong Buy Ratings
$67.39
▼ -0.62 (-0.91%)

This chart shows the closing price for MET by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New MetLife Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MET and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MET

Analyst Price Target is $76.91
▲ +14.13% Upside Potential
This price target is based on 10 analysts offering 12 month price targets for MetLife in the last 3 months. The average price target is $76.91, with a high forecast of $83.00 and a low forecast of $74.00. The average price target represents a 14.13% upside from the last price of $67.39.

This chart shows the closing price for MET for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 10 polled investment analysts is to buy stock in MetLife. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 11 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/25/2021
  • 0 strong buy ratings
  • 12 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/26/2021
  • 0 strong buy ratings
  • 10 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/24/2021
  • 0 strong buy ratings
  • 10 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/22/2021
  • 0 strong buy ratings
  • 11 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/20/2022
  • 0 strong buy ratings
  • 9 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/21/2022
  • 0 strong buy ratings
  • 10 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/20/2022
  • 0 strong buy ratings
  • 10 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/19/2022

Latest Recommendations

  • 0 strong buy ratings
  • 10 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/17/2022Morgan StanleyBoost TargetOverweight$79.00 ➝ $83.00Low
8/9/2022Evercore ISIBoost Target$81.00Low
8/4/2022Morgan StanleyBoost TargetOverweight$78.00 ➝ $79.00N/A
7/19/2022BarclaysSet Target$75.00Low
7/13/2022BarclaysLower TargetOverweight$79.00 ➝ $75.00N/A
7/11/2022JPMorgan Chase & Co.Lower Target$75.00 ➝ $74.00N/A
7/6/2022Evercore ISILower TargetOutperform$81.00 ➝ $80.00N/A
7/6/2022Morgan StanleyLower TargetOverweight$80.00 ➝ $78.00N/A
6/22/2022Wolfe ResearchUpgradeMarket Perform ➝ Outperform$70.00 ➝ $74.00Low
5/23/2022CitigroupInitiated CoverageBuy$77.00Low
4/12/2022BarclaysBoost TargetOverweight$76.00 ➝ $79.00Low
4/6/2022Piper SandlerBoost TargetOverweight$77.00 ➝ $80.00Medium
4/5/2022JPMorgan Chase & Co.Boost Target$69.00 ➝ $75.00N/A
2/22/2022Morgan StanleyBoost TargetOverweight$76.00 ➝ $79.00Medium
1/25/2022Jefferies Financial GroupInitiated CoverageBuy$74.00Low
1/21/2022Wolfe ResearchInitiated CoverageMarket Perform$70.00Low
1/12/2022UBS GroupBoost TargetBuy$74.00 ➝ $77.00Low
1/11/2022BarclaysBoost TargetOverweight$72.00 ➝ $75.00Low
1/7/2022Morgan StanleyBoost TargetOverweight$75.00 ➝ $76.00Low
1/5/2022Evercore ISIUpgradeIn-Line ➝ Outperform$67.00 ➝ $75.00High
1/4/2022Wells Fargo & CompanyLower TargetOverweight$75.00 ➝ $74.00Low
12/2/2021The Goldman Sachs GroupInitiated CoverageBuy$77.00Low
10/14/2021Morgan StanleyBoost TargetOverweight$74.00 ➝ $75.00Low
10/12/2021BarclaysBoost TargetOverweight$69.00 ➝ $72.00Low
8/5/2021Morgan StanleyBoost TargetOverweight$73.00 ➝ $74.00Low
7/15/2021Morgan StanleyBoost TargetOverweight$72.00 ➝ $73.00Low
5/13/2021Credit Suisse GroupBoost TargetOutperform$55.00 ➝ $68.00Medium
5/7/2021Royal Bank of CanadaBoost TargetOutperform$66.00 ➝ $74.00Low
5/6/2021Morgan StanleyBoost TargetOverweight$70.00 ➝ $72.00High
4/26/2021UBS GroupInitiated CoverageBuy$72.00N/A
4/20/2021UBS GroupInitiated CoverageBuy$72.00Medium
4/12/2021BarclaysBoost TargetOverweight$65.00 ➝ $69.00Low
4/5/2021JPMorgan Chase & Co.Boost TargetCautious ➝ Overweight$58.00 ➝ $64.00Low
4/1/2021Royal Bank of CanadaBoost Target$57.00 ➝ $66.00Low
4/1/2021Morgan StanleyBoost TargetOverweight$60.00 ➝ $70.00Low
3/31/2021CitigroupBoost Target$58.00 ➝ $69.00Low
2/25/2021Morgan StanleyBoost TargetOverweight$58.00 ➝ $60.00Medium
2/23/2021BarclaysBoost TargetOverweight$53.00 ➝ $60.00Low
2/17/2021ArgusBoost TargetPositive ➝ Buy$53.00 ➝ $63.00Low
2/4/2021Morgan StanleyBoost TargetOverweight$57.00 ➝ $58.00High
1/15/2021Morgan StanleyBoost TargetOverweight$53.00 ➝ $57.00Low
1/6/2021Piper SandlerUpgradeNeutral ➝ Overweight$45.00 ➝ $52.00N/A
12/13/2020BarclaysReiterated RatingBuy$53.00Medium
12/8/2020Smith Barney CitigroupUpgradeNeutral ➝ Buy$39.00 ➝ $55.00Low
12/4/2020The Goldman Sachs GroupInitiated CoverageNeutral$48.00Low
11/18/2020Morgan StanleyBoost TargetOverweight$49.00 ➝ $53.00Medium
11/17/2020Credit Suisse GroupBoost TargetOutperform ➝ Positive$46.00 ➝ $55.00Low
11/17/2020BarclaysInitiated CoverageOverweight$52.00Low
11/5/2020Morgan StanleyBoost TargetOverweight$47.00 ➝ $49.00High
10/6/2020Morgan StanleyBoost TargetOverweight$46.00 ➝ $47.00Medium
9/18/2020Credit Suisse GroupReiterated RatingBuy$46.00Low
8/20/2020Morgan StanleyBoost TargetOverweight$44.00 ➝ $46.00Low
8/19/2020ArgusReiterated RatingBuyLow
8/6/2020Wells Fargo & CompanyReiterated RatingBuy$45.00Medium
7/6/2020Morgan StanleyBoost TargetOverweight$40.00 ➝ $44.00Low
6/1/2020Bank of AmericaInitiated CoverageBuyLow
5/8/2020Royal Bank of CanadaBoost TargetOutperform$42.00 ➝ $44.00Medium
5/7/2020Morgan StanleyBoost TargetOverweight$38.00 ➝ $40.00Medium
4/27/2020Credit Suisse GroupLower TargetOutperform$60.00 ➝ $46.00Low
4/3/2020Piper SandlerLower TargetNeutral$38.00 ➝ $33.00Medium
4/1/2020Wells Fargo & CompanyLower TargetOverweight$59.00 ➝ $44.00Medium
3/20/2020Royal Bank of CanadaLower Target$57.00 ➝ $42.00High
3/17/2020Morgan StanleyLower TargetOverweight$60.00 ➝ $38.00High
3/16/2020CitigroupUpgradeSell ➝ Neutral$46.00 ➝ $32.00Medium
3/10/2020Piper SandlerLower TargetNeutral$51.00 ➝ $38.00Medium
2/27/2020Piper SandlerLower TargetNeutral$55.00 ➝ $51.00High
2/9/2020Royal Bank of CanadaReiterated RatingBuy$57.00Low
2/3/2020Credit Suisse GroupLower TargetOutperform$63.00 ➝ $60.00Low
1/7/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$55.00 ➝ $60.00Low
1/6/2020Wells Fargo & CompanyReiterated RatingBuyN/A
12/9/2019Wells Fargo & CompanyReiterated RatingBuyLow
10/15/2019B. RileyReiterated RatingNeutralMedium
10/10/2019UBS GroupBoost TargetNeutral$46.00 ➝ $47.00Low
9/13/2019CitigroupLower TargetSell$42.00 ➝ $41.00Low
8/20/2019Morgan StanleyLower TargetEqual Weight$54.00 ➝ $53.00Low
7/11/2019Wells Fargo & CompanyBoost TargetOutperform$55.00 ➝ $57.00Low
7/10/2019Morgan StanleyBoost TargetEqual Weight$52.00 ➝ $53.00Low
6/5/2019Wells Fargo & CompanyReiterated RatingBuy$55.00Low
5/23/2019CitigroupSet TargetSell$42.00Low
5/22/2019BarclaysBoost TargetOverweight$52.00 ➝ $55.00Low
5/21/2019Wells Fargo & CompanyReiterated RatingBuy$55.00Low
4/12/2019Deutsche Bank AktiengesellschaftBoost TargetHold$46.00 ➝ $47.00Medium
4/9/2019UBS GroupBoost TargetNeutral ➝ Neutral$45.00 ➝ $48.00Low
3/19/2019Sandler O'NeillDowngradeBuy ➝ Hold$50.00Low
2/12/2019ArgusReiterated RatingBuyMedium
1/16/2019Bank of AmericaUpgradeNeutral ➝ Buy$44.06Low
1/8/2019Wells Fargo & CompanyReiterated RatingBuyLow
1/2/2019Sandler O'NeillUpgradeHold ➝ BuyMedium
12/17/2018Royal Bank of CanadaLower TargetOutperform ➝ Outperform$57.00 ➝ $50.00Low
12/13/2018Wells Fargo & CompanySet TargetBuy$60.00Medium
11/13/2018Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$52.00 ➝ $54.00Low
11/2/2018Wells Fargo & CompanySet TargetBuy$60.00Low
10/8/2018UBS GroupBoost TargetNeutral ➝ Neutral$48.00 ➝ $49.00Low
9/27/2018Wells Fargo & CompanyReiterated RatingBuy$60.00Low
8/17/2018Credit Suisse GroupLower TargetOutperform ➝ Outperform$67.00 ➝ $63.00Low
8/2/2018Sandler O'NeillReiterated RatingHold$50.00Medium
7/16/2018B. RileyLower TargetNeutral ➝ Neutral$58.00 ➝ $50.00Low
7/11/2018Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$53.00 ➝ $52.00Medium
7/9/2018BarclaysLower TargetOverweight ➝ Overweight$60.00 ➝ $57.00High
6/4/2018The Goldman Sachs GroupDowngradeBuy ➝ Neutral$55.91 ➝ $61.00Low
5/8/2018Wells Fargo & CompanyReiterated RatingBuyLow
5/4/2018Deutsche Bank AktiengesellschaftLower TargetHold ➝ Hold$51.00 ➝ $48.00Medium
5/1/2018Wells Fargo & CompanyReiterated RatingBuyLow
4/25/2018Credit Suisse GroupInitiated CoverageOutperform ➝ Outperform$67.00Low
4/5/2018Sandler O'NeillSet TargetHold$47.00Low
4/5/2018Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$58.00 ➝ $56.00Low
3/26/2018Bank of AmericaInitiated CoverageNeutral$50.00High
3/26/2018Atlantic SecuritiesUpgradeNeutral ➝ OverweightHigh
3/16/2018Wells Fargo & CompanyReiterated RatingBuy$60.00Low
3/2/2018UBS GroupReiterated RatingNeutral ➝ Neutral$52.00 ➝ $51.00Low
3/1/2018Wells Fargo & CompanyReiterated RatingBuy$60.00Low
2/23/2018Keefe, Bruyette & WoodsReiterated RatingBuy$56.00Low
2/14/2018Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$59.00 ➝ $58.00High
2/13/2018Wells Fargo & CompanySet TargetBuy$60.00High
1/31/2018The Goldman Sachs GroupReiterated RatingConviction-Buy ➝ BuyHigh
1/30/2018Wells Fargo & CompanyLower TargetBuy$61.00 ➝ $60.00High
1/2/2018Deutsche Bank AktiengesellschaftInitiated CoverageHold$55.00Medium
12/14/2017Wells Fargo & CompanySet TargetBuy$62.00High
11/10/2017Sandler O'NeillDowngradeBuy ➝ HoldN/A
11/6/2017B. RileyReiterated RatingNeutralN/A
11/6/2017ArgusBoost TargetBuy$55.00 ➝ $60.00N/A
11/3/2017Morgan StanleyBoost TargetEqual Weight$55.00 ➝ $56.00N/A
11/3/2017Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$56.00 ➝ $60.00N/A
10/18/2017Wells Fargo & CompanyReiterated RatingBuyN/A
10/18/2017The Goldman Sachs GroupInitiated CoverageConviction-Buy$61.00N/A
10/10/2017FBR & Co.DowngradeBuy ➝ Neutral$53.00 ➝ $52.00N/A
10/5/2017Morgan StanleyBoost TargetEqual Weight$54.00 ➝ $55.00N/A
10/3/2017Wells Fargo & CompanyReiterated RatingOutperform$55.00 ➝ $60.00Low
9/6/2017Royal Bank of CanadaReiterated RatingBuy$56.00Medium
9/1/2017UBS GroupReiterated RatingNeutral$57.00 ➝ $49.00Low
8/29/2017FBR & Co.Reiterated RatingBuy$53.00Low
8/28/2017Credit Suisse GroupReiterated RatingNeutral$64.00 ➝ $53.00Low
(Data available from 8/19/2017 forward)

News Sentiment Rating

0.31 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 6 very positive mentions
  • 28 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
1/21/2022
  • 6 very positive mentions
  • 45 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
2/20/2022
  • 7 very positive mentions
  • 19 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
3/22/2022
  • 8 very positive mentions
  • 19 positive mentions
  • 3 negative mentions
  • 2 very negative mentions
4/21/2022
  • 11 very positive mentions
  • 38 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
5/21/2022
  • 3 very positive mentions
  • 26 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/20/2022
  • 4 very positive mentions
  • 19 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
7/20/2022
  • 9 very positive mentions
  • 46 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
8/19/2022

Current Sentiment

  • 9 very positive mentions
  • 46 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
MetLife logo
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
Read More

Today's Range

Now: $67.39
Low: $67.21
High: $67.73

50 Day Range

MA: $62.87
Low: $57.91
High: $68.01

52 Week Range

Now: $67.39
Low: $57.05
High: $73.18

Volume

3,138,337 shs

Average Volume

4,517,039 shs

Market Capitalization

$54.80 billion

P/E Ratio

16.76

Dividend Yield

2.94%

Beta

1.08

Frequently Asked Questions

What sell-side analysts currently cover shares of MetLife?

The following Wall Street analysts have issued research reports on MetLife in the last twelve months: Barclays PLC, Citigroup Inc., Evercore ISI, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Piper Sandler, StockNews.com, The Goldman Sachs Group, Inc., TheStreet, UBS Group AG, Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for MET.

What is the current price target for MetLife?

11 Wall Street analysts have set twelve-month price targets for MetLife in the last year. Their average twelve-month price target is $76.91, suggesting a possible upside of 14.1%. Morgan Stanley has the highest price target set, predicting MET will reach $83.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $74.00 for MetLife in the next year.
View the latest price targets for MET.

What is the current consensus analyst rating for MetLife?

MetLife currently has 10 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MET will outperform the market and that investors should add to their positions of MetLife.
View the latest ratings for MET.

What other companies compete with MetLife?

How do I contact MetLife's investor relations team?

MetLife's physical mailing address is 200 PARK AVENUE, NEW YORK NY, 10166. The financial services provider's listed phone number is (212) 578-9500. The official website for MetLife is www.metlife.com. Learn More about contacing MetLife investor relations.